204 related articles for article (PubMed ID: 33497276)
1. Differential diagnosis of renal oncocytoma and chromophobe renal cell carcinoma using CT features: a central scar-matched retrospective study.
Li X; Nie P; Zhang J; Hou F; Ma Q; Cui J
Acta Radiol; 2022 Feb; 63(2):253-260. PubMed ID: 33497276
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of CT appearances in renal oncocytoma and chromophobe renal cell carcinoma.
Wu J; Zhu Q; Zhu W; Chen W; Wang S
Acta Radiol; 2016 Apr; 57(4):500-6. PubMed ID: 25972369
[TBL] [Abstract][Full Text] [Related]
3. A CT-based radiomics nomogram for differentiation of renal oncocytoma and chromophobe renal cell carcinoma with a central scar-matched study.
Li X; Ma Q; Nie P; Zheng Y; Dong C; Xu W
Br J Radiol; 2022 Jan; 95(1129):20210534. PubMed ID: 34735296
[TBL] [Abstract][Full Text] [Related]
4. Comparison of computed tomography findings between renal oncocytomas and chromophobe renal cell carcinomas.
Choi JH; Kim JW; Lee JY; Han WK; Rha KH; Choi YD; Hong SJ; Yoon YE
Korean J Urol; 2015 Oct; 56(10):695-702. PubMed ID: 26495070
[TBL] [Abstract][Full Text] [Related]
5. Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma.
Amin J; Xu B; Badkhshan S; Creighton TT; Abbotoy D; Murekeyisoni C; Attwood KM; Schwaab T; Hendler C; Petroziello M; Roche CL; Kauffman EC
Clin Cancer Res; 2018 Aug; 24(16):3898-3907. PubMed ID: 29752278
[No Abstract] [Full Text] [Related]
6. Aorta-Lesion-Attenuation-Difference (ALAD) on contrast-enhanced CT: a potential imaging biomarker for differentiating malignant from benign oncocytic neoplasms.
Dhyani M; Grajo JR; Rodriguez D; Chen Z; Feldman A; Tambouret R; Gervais DA; Arellano RS; Hahn PF; Samir AE
Abdom Radiol (NY); 2017 Jun; 42(6):1734-1743. PubMed ID: 28197683
[TBL] [Abstract][Full Text] [Related]
7. Use of specific contrast-enhanced CT regions of interest to differentiate renal oncocytomas from small clear cell and chromophobe renal cell carcinomas.
Qu JY; Jiang H; Wang XF; Song XH; Hao CJ
Diagn Interv Radiol; 2022 Nov; 28(6):555-562. PubMed ID: 36550755
[TBL] [Abstract][Full Text] [Related]
8. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.
Liu YJ; Ussakli C; Antic T; Liu Y; Wu Y; True L; Tretiakova MS
Hum Pathol; 2020 Oct; 104():18-29. PubMed ID: 32673684
[TBL] [Abstract][Full Text] [Related]
9. CT differentiation of the oncocytoma and renal cell carcinoma based on peripheral tumor parenchyma and central hypodense area characterisation.
Qu J; Zhang Q; Song X; Jiang H; Ma H; Li W; Wang X
BMC Med Imaging; 2023 Jan; 23(1):16. PubMed ID: 36707788
[TBL] [Abstract][Full Text] [Related]
10. HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies.
Conner JR; Hirsch MS; Jo VY
Cancer Cytopathol; 2015 May; 123(5):298-305. PubMed ID: 25739652
[TBL] [Abstract][Full Text] [Related]
11. Nomogram predictive model for differentiation between renal oncocytoma and chromophobe renal cell carcinoma at multi-phasic CT: a retrospective study.
Elsayed Sharaf D; Shebel H; El-Diasty T; Osman Y; Khater SM; Abdelhamid M; Abou El Atta HM
Clin Radiol; 2022 Oct; 77(10):767-775. PubMed ID: 35764438
[TBL] [Abstract][Full Text] [Related]
12. Role of computed tomography features in the differential diagnosis of chromophobe renal cell carcinoma from oncocytoma and angiomyolipoma without visible fat.
Zhou C; Ban X; Lv J; Cheng L; Xu J; Shen X
Quant Imaging Med Surg; 2022 Apr; 12(4):2332-2343. PubMed ID: 35371954
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of segmental enhancement inversion for the diagnosis of renal oncocytoma using biphasic computed tomography (CT) and multiphase contrast-enhanced magnetic resonance imaging (MRI).
Schieda N; Al-Subhi M; Flood TA; El-Khodary M; McInnes MD
Eur Radiol; 2014 Nov; 24(11):2787-94. PubMed ID: 25027841
[TBL] [Abstract][Full Text] [Related]
14. Differentiation between renal oncocytomas and chromophobe renal cell carcinomas using dynamic contrast-enhanced computed tomography.
Guo K; Ren S; Cao Y; Zhang H; Zhang Y; Gu X; Wang Z
Abdom Radiol (NY); 2021 Jul; 46(7):3309-3316. PubMed ID: 33710383
[TBL] [Abstract][Full Text] [Related]
15. Value of radiomics in differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma.
Li Y; Huang X; Xia Y; Long L
Abdom Radiol (NY); 2020 Oct; 45(10):3193-3201. PubMed ID: 31664486
[TBL] [Abstract][Full Text] [Related]
16. HNF-1β as an immunohistochemical marker for distinguishing chromophobe renal cell carcinoma and hybrid oncocytic tumors from renal oncocytoma.
An J; Park CK; Kim M; Joo JW; Cho NH
Virchows Arch; 2021 Mar; 478(3):459-470. PubMed ID: 32816058
[TBL] [Abstract][Full Text] [Related]
17. Small renal masses (≤ 4 cm): differentiation of oncocytoma from renal clear cell carcinoma using ratio of lesion to cortex attenuation and aorta-lesion attenuation difference (ALAD) on contrast-enhanced CT.
Gentili F; Bronico I; Maestroni U; Ziglioli F; Silini EM; Buti S; de Filippo M
Radiol Med; 2020 Dec; 125(12):1280-1287. PubMed ID: 32385827
[TBL] [Abstract][Full Text] [Related]
18. Four-phase computed tomography helps differentiation of renal oncocytoma with central hypodense areas from clear cell renal cell carcinoma.
Qu JY; Jiang H; Song XH; Wu JK; Ma H
Diagn Interv Radiol; 2023 Mar; 29(2):205-211. PubMed ID: 36960636
[TBL] [Abstract][Full Text] [Related]
19. Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma.
Ruiz-Cordero R; Rao P; Li L; Qi Y; Atherton D; Peng B; Singh RR; Kim TB; Kawakami F; Routbort MJ; Alouch N; Chow CB; Tang X; Lu W; Brimo F; Matin SF; Wood CG; Tannir NM; Wistuba II; Chen K; Wang J; Medeiros LJ; Karam JA; Tamboli P; Sircar K
Mod Pathol; 2019 Nov; 32(11):1698-1707. PubMed ID: 31231128
[TBL] [Abstract][Full Text] [Related]
20. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
